{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:50:24Z","timestamp":1791449424593,"version":"4.3.3"},"reference-count":103,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is a chronic systemic inflammatory disease with various co-morbidities, having been recently considered as a comprehensive disease named psoriatic disease or psoriatic syndrome. Autoimmune diseases are one form of its co-morbidities. In addition to the genetic background, shared pathogenesis including innate immunity, neutrophil extracellular trap (NETs), and type I interferon, as well as acquitted immunity such as T helper-17 (Th17) related cytokines are speculated to play a significant role in both psoriasis and connective tissue diseases. On the other hand, there are definite differences between psoriasis and connective tissue diseases, such as their pathomechanisms and response to drugs. Therefore, we cannot expect that one stone kills two birds, and thus caution is necessary when considering whether the administered drug for one disease is effective or not for another disease. In this review, several connective tissue diseases and related diseases are discussed from the viewpoint of their coexistence with psoriasis.<\/jats:p>","DOI":"10.3390\/ijms21165803","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:58:02Z","timestamp":1597287482000},"page":"5803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Psoriasis and Connective Tissue Diseases"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-2573","authenticated-orcid":false,"given":"Toshiyuki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Dermatology, Fukushima Medical and Dental University, Hikarigaoka 1, Fukushima 960-1295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"ref_1","first-page":"210","article-title":"Psoriasis, psoriatic arthritis, or psoriatic disease?","volume":"33","author":"Scarpa","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1468-3083.2010.03574.x","article-title":"Psoriatic disease: Concepts and implications","volume":"24","author":"Scarpa","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3899\/jrheum.190054","article-title":"Psoriatic Arthritis, Psoriatic Disease, or Psoriatic Syndrome?","volume":"46","author":"Lubrano","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","article-title":"The association of psoriasis with autoimmune diseases","volume":"67","author":"Wu","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ad.2011.03.002","article-title":"Connective Tissue Diseases and Psoriasis","volume":"102","year":"2011","journal-title":"Actas Dermosifiliog."},{"key":"ref_6","first-page":"3","article-title":"Psoriasis and systemic lupus erythematosus: A rare association with specific therapeutic problems","volume":"154","author":"Astudillo","year":"2003","journal-title":"Ann. Med. Interne"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archderm.1980.01640300046015","article-title":"The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases","volume":"116","author":"Millns","year":"1980","journal-title":"Arch. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0190-9622(84)80267-4","article-title":"The coexistence of systemic lupus erythematosus and psoriasis","volume":"10","author":"Hays","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","first-page":"1","article-title":"The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders","volume":"195","author":"Zalla","year":"1996","journal-title":"Acta Derm. Venereol. Suppl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10067-017-3566-0","article-title":"Psoriasis in systemic lupus erythematosus: A single-center experience","volume":"36","author":"Tselios","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5114\/reum.2020.93516","article-title":"Psoriasis and systemic lupus erythematosus in children: Literature review based on case report","volume":"58","year":"2020","journal-title":"Rheumatologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: New insights into pathogenesis and therapeutic strategies","volume":"15","author":"Wenzel","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritis cells (natural interferon-\u03b1\/\u03b2-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2014.01.892","article-title":"Comparative analysis of rosacea and cutaneous lupus erythematosus: Histopathologic features, T-cell subsets, and plasmacytoid dendritic cells","volume":"71","author":"Brown","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kato, Y., and Yamamoto, T. (2020). Ulcerative lupus erythematosus profundus in a patient with systemic lupus erythematosus and psoriasis. J. Dermatol., 47.","DOI":"10.1111\/1346-8138.15423"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-019-0842-9","article-title":"Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus","volume":"21","author":"Tumurkhuu","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","article-title":"Cardiovascular disease in systemic lupus erythematosus","volume":"30","author":"Liu","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1684\/ejd.2019.3517","article-title":"Imiquimod-induced widespread psoriasiform eruptions","volume":"29","author":"Igari","year":"2019","journal-title":"Eur. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice: A New Model of Systemic Lupus Erythematosus","volume":"66","author":"Yokogawa","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62480-3","article-title":"Native\/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus","volume":"10","author":"Lande","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2133.2010.10002.x","article-title":"A case of generalized psoriasiform and pustular eruption induced by infliximab: Evidence for skin-homing Th17 in the pathogenesis","volume":"163","author":"Teraki","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","article-title":"Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: Results of a multicentre, double-blind, phase 2, randomised, controlled study","volume":"392","author":"Hahn","year":"2018","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1346-8138.2000.tb02180.x","article-title":"A rare association of systemic sclerosis with psoriasis vulgaris","volume":"27","author":"Yamamoto","year":"2000","journal-title":"J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_27","first-page":"487","article-title":"Morphea in a Patient With Psoriasis on Treatment with Ustekinumab: Comorbidity or Adverse Effect?","volume":"108","author":"Taberner","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ Cell Counts Are Increased in Systemic Sclerosis Skin and Their Number Is Inversely Correlated With the Extent of Skin Involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_31","first-page":"S14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol. Lett."},{"key":"ref_33","first-page":"1","article-title":"IL-17 and related cytokines involved in systemic sclerosis: Perspectives","volume":"51","author":"Pereira","year":"2017","journal-title":"Autoimmunity"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cyto.2018.11.003","article-title":"Interleukin-17: Friend or foe in organ fibrosis","volume":"120","author":"Ramani","year":"2019","journal-title":"Cytokine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","article-title":"IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis","volume":"140","author":"Dufour","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2016.09.009","article-title":"Human innate lymphoid cells","volume":"138","author":"Spits","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2018.07.002","article-title":"Innate lymphoid cells in organ fibrosis","volume":"42","author":"Mikami","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_38","first-page":"958","article-title":"Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: A role for a gram-positive inflammatory trigger?","volume":"29","author":"Carrasco","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-2133.2012.11149.x","article-title":"Concepts in psoriasis: Psoriasis and the extracellular matrix","volume":"167","author":"McFadden","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physrev.00052.2009","article-title":"Hyaluronan as an Immune Regulator in Human Diseases","volume":"91","author":"Jiang","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/BOR.0000000000000542","article-title":"Innate immunity and toll-like receptor signaling in the pathogenesis of scleroderma: Advances and opportunities for therapy","volume":"30","author":"Brown","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The Role of Type 1 Interferon in Systemic Sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances","volume":"9","author":"Laurent","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Kioon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"98380","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2133.2008.08456.x","article-title":"Psoriasis is associated with increased levels of serum leptin","volume":"158","author":"Wang","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2133.2008.08742.x","article-title":"Serum leptin levels, skin leptin and leptin receptor expression in psoriasis","volume":"159","author":"Bozkurt","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_49","first-page":"1207","article-title":"Plasma adiponectin and leptin levels in Japanese patients with psoriasis","volume":"159","author":"Takahashi","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00403-019-01893-1","article-title":"The role of adipokines in systemic sclerosis: A missing link?","volume":"311","author":"Stochmal","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.semarthrit.2016.08.014","article-title":"The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?","volume":"46","author":"Klavdianou","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_53","first-page":"45","article-title":"Dickkopf-1 is downregulated early and universally in the skin of patients with systemic sclerosis despite normal circulating levels","volume":"36","author":"Daoussis","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells from a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","article-title":"Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome","volume":"138","author":"Classon","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jaci.2018.08.048","article-title":"A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis","volume":"143","author":"Hoffer","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.17748","article-title":"CD 8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis","volume":"137","author":"Li","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_60","first-page":"219","article-title":"Skin resident memory T-cell population is not constructed effectively in systemic sclerosis","volume":"180","author":"Watanabe","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1468-3083.2009.03089.x","article-title":"Dermatofibroma: A possible model of local fibrosis with epithelial\/mesenchymal cell interaction","volume":"23","author":"Yamamoto","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jdermsci.2019.04.007","article-title":"Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?","volume":"94","author":"Asano","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2298\/VSP0405557P","article-title":"Psoriasis in a patient with dermatomyositis","volume":"61","author":"Zolotarevski","year":"2004","journal-title":"Vojn. Pregl."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archdermatol.2011.49","article-title":"Double trouble: Therapeutic challenge in patients with both juvenile dermatomyositis and psoriasis","volume":"147","author":"Kim","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5070\/D3238036019","article-title":"Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine","volume":"23","author":"Inkeles","year":"2017","journal-title":"Dermatol. Online J."},{"key":"ref_66","first-page":"557","article-title":"Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease","volume":"61","author":"Kato","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/RHU.0000000000000430","article-title":"A Rare Case of Amyopathic Juvenile Dermatomyositis Associated With Psoriasis Successfully Treated With Ustekinumab","volume":"23","author":"Montoya","year":"2017","journal-title":"J. Clin. Rheumatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J. Cutan. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells","volume":"62","author":"Shrestha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_70","first-page":"656","article-title":"Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis","volume":"37","author":"Silva","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","article-title":"Type I interferon pathway in adult and juvenile dermatomyositis","volume":"13","author":"Baechler","year":"2011","journal-title":"Arthritis Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamadermatol.2019.1668","article-title":"Distinct Histopathologic Patterns of Finger Eruptions in Dermatomyositis Based on Myositis-Specific Autoantibody Profiles","volume":"155","author":"Okiyama","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","article-title":"Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis","volume":"40","author":"Shen","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1038\/s41598-018-23539-4","article-title":"Interleukin-23 as a therapeutic target for inflammatory myopathy","volume":"8","author":"Umezawa","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/kez020","article-title":"Successful treatment of refractory mechanic\u2019s hands with ustekinumab in a patient with the antisynthetase syndrome","volume":"58","author":"Kroodsma","year":"2019","journal-title":"Rheumatology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Verstappen, G.M., Kroese, F.G.M., and Bootsma, H. (2019). T cells in primary Sj\u00f6gren\u2019s syndrome: Targets for early intervention. Rheumatology.","DOI":"10.1093\/rheumatology\/kez004"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12016-017-8639-y","article-title":"Cutaneous and Mucosal Manifestations of Sj\u00f6gren\u2019s Syndrome","volume":"53","author":"Generali","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1346-8138.1996.tb03972.x","article-title":"Association of Generalized Pustular Psoriasis, Sj\u00f6ogren Syndrome, and Hashimoto\u2019s Thyroiditis","volume":"23","author":"Yamamoto","year":"1996","journal-title":"J. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(96)00537-3","article-title":"Overlapping cases with psoriasis and Sj\u00f6gren syndrome: A study of lymphocyte response to staphylococcal enterotoxin B","volume":"13","author":"Yamamoto","year":"1996","journal-title":"J. Dermatol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1346-8138.13265","article-title":"Association of psoriasis with Hashimoto\u2019s thyroiditis, Sj\u00f6gren\u2019s syndrome and dermatomyositis","volume":"43","author":"Akiyama","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5021\/ad.2014.26.2.203","article-title":"Immunohistochemical Analysis of Interleukin-17 Producing T Helper Cells and Regulatory T Cells Infiltration in Annular Erythema Associated with Sj\u00f6gren\u2019s Syndrome","volume":"26","author":"Itoi","year":"2014","journal-title":"Ann. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3315\/jdcr.2015.1207","article-title":"Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sj\u00f6gren syndrome. Report of two cases and review of literature","volume":"9","author":"Chimenti","year":"2015","journal-title":"J. Dermatol. Case Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00296-009-0881-z","article-title":"Cutaneous manifestations associated with rheumatoid arthritis","volume":"29","author":"Yamamoto","year":"2009","journal-title":"Rheumatol. Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/cimm.1996.0272","article-title":"Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells","volume":"173","author":"Dao","year":"1996","journal-title":"Cell. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.23088","article-title":"Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still\u2019s disease","volume":"57","author":"Chen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","article-title":"Potential role of Th17 cells in the pathogenesis of adult-onset Still\u2019s disease","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: The Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00296-011-2330-z","article-title":"Cutaneous manifestations associated with adult-onset Still\u2019s disease: Important diagnostic values","volume":"32","author":"Yamamoto","year":"2011","journal-title":"Rheumatol. Int."},{"key":"ref_89","first-page":"e109","article-title":"Case of adult-onset Still\u2019s disease with psoriasiform eruptions","volume":"46","author":"Ito","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_90","first-page":"e53","article-title":"Adult-onset Still\u2019s disease in a patient with psoriasis vulgaris showing inverse correlation of disease activity","volume":"45","author":"Kabuto","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.clindermatol.2018.04.010","article-title":"Inflammatory arthritis and crystal arthropathy: Current concepts of skin and systemic manifestations","volume":"36","author":"Fazel","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7241\/ourd.20184.32","article-title":"Drug-induced hypersensitivity syndrome in a patient with systemic lupus erythematosus and psoriasis","volume":"9","author":"Miura","year":"2019","journal-title":"Our Dermatol. Online"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s Disease: An Overview of Etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1346-8138.2005.tb00735.x","article-title":"Psoriasis Associated with Beh\u00e7et\u2019s Disease","volume":"32","author":"Ujihara","year":"2005","journal-title":"J. Dermatol."},{"key":"ref_95","first-page":"e113","article-title":"Beh\u00e7et\u2019s disease in concurrence with psoriasis","volume":"27","author":"Choi","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.13049","article-title":"Is Beh\u00e7et\u2019s disease a \u2018class 1-opathy\u2019? The role of HLA-B*51 in the pathogenesis of Beh\u00e7et\u2019s disease","volume":"191","author":"Giza","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2019MHC-I-opathy\u2019\u2014Unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamadermatol.2013.4256","article-title":"Sarcoidosis and psoriasis: A case series and review of the literature exploring co-incidence vs coincidence","volume":"149","author":"Wanat","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","article-title":"TNF-\u03b1: A treatment target or cause of sarcoidosis?","volume":"29","author":"Amber","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"Berge","year":"2011","journal-title":"Rheumatology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/clin.1996.0161","article-title":"Detection of Psoriasis-Associated Antigen pso p27 in Sarcoidosis Bronchoalveolar Lavage Fluid Using Monoclonal Antibodies","volume":"81","author":"Jacobsen","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/16\/5803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:59:57Z","timestamp":1760176797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/16\/5803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":103,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["ijms21165803"],"URL":"https:\/\/doi.org\/10.3390\/ijms21165803","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}